TrialJCI insight2023

Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial.

Diana C Gomez-Manjarres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.